查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866381

实验室自动化市场－2025-2030年预测

Laboratory Automation Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

实验室自动化市场预计将从 2025 年的 54.06 亿美元成长到 2030 年的 76.71 亿美元，复合年增长率为 7.25%。

实验室自动化系统利用先进的仪器设备简化实验室流程，最大限度地减少人为干预，从而提高效率、准确性和安全性。这些系统优化了从单一步骤到整个工作流程的各项任务，减少了试剂用量，最大限度地减少了废弃物，并提高了实验通量。在人们对自动化优势的认识不断提高、技术进步以及药物研发和生物技术领域投资不断增长的推动下，全球实验室自动化市场预计将稳步成长。然而，高昂的生产和实施成本，以及中小企业（SME）的缓慢采用，可能会阻碍市场扩张。

市场驱动因素

硬体领域的优势

硬体领域（包括实验室机器人和自动化工作站）占据了最大的市场份额。对加速研发和药物开发日益增长的需求推动了对这些组件的需求，这些组件能够提高生产效率并简化复杂流程。特别是自动化工作站，由于其能够高效处理高工作负载，有助于实验室运作的扩充性，从而推动市场成长，并因此得到了广泛应用。

临床化学应用

临床化学领域凭藉自动化技术在人员配备较少的情况下处理大量工作，占据了市场主导地位。对具备结果管理、储存和归檔等自动化功能的专业实验室的需求不断增长，进一步推动了市场需求。临床化学领域的自动化提高了准确性并缩短了前置作业时间，符合业界对营运效率和数据可靠性的追求。

市场限制

开发和实施自动化系统的高成本构成了一大障碍，尤其对于预算有限的中小型企业而言更是如此。此外，基础设施和专业知识的匮乏也减缓了小型实验室采用先进技术的步伐，限制了市场渗透率。应对这些挑战需要经济高效的解决方案和提高公众意识，这将有助于技术的更广泛应用。

市场区隔分析

根据交付方式，市场可分为硬体和软体两部分，其中硬体因其在自动化系统中的重要性而占据主导地位。根据应用领域，临床化学占据最大份额，这主要得益于对高通量的需求；其次是药物研发和基因组学。生技和製药产业是最大的终端用户，其需求主要来自管理产品复杂性、降低营运成本、透过自动化加速药物研发。其他终端使用者包括学术研究机构和临床诊断实验室。

从地区来看，北美预计将占据最大的市场份额，这得益于其先进的医疗保健基础设施、创新技术的广泛应用以及主要企业的存在；而亚太地区预计将实现最快的增长，这得益于医疗保健投资的增加、研发领域的快速发展以及中国和印度等国家技术的日益普及。

竞争格局

罗氏等主要企业正透过人工智慧、机器学习和机器人等先进解决方案推动创新。这些企业正积极推行合作策略，包括产品发布和伙伴关係，以拓展市场影响。其重点在于为生物技术和製药行业的终端用户提供可扩展且高效的自动化系统，从而提高生产效率和数据准确性。

区域分析

北美地区的领先地位归功于其强大的医疗保健生态系统和对自动化技术的早期应用，而亚太地区则凭藉不断增长的医疗基础设施投资和日益活跃的研发活动，成为成长热点。南美洲新兴市场也蕴藏着机会，但成本限制减缓了科技的普及。

实验室自动化市场预计将迎来强劲成长，这主要得益于硬体技术的进步、临床化学应用以及生物技术/製药产业的需求。北美市场主导，而亚太地区的快速发展也展现出巨大的潜力。儘管高成本和中小企业采用自动化技术的障碍仍然存在，但人工智慧和机器人技术的持续创新和策略性投资将有助于保持市场成长势头，并提高实验室流程的效率和安全性。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 按组件分類的实验室自动化市场

  • 介绍
  • 硬体
  • 软体
  • 服务

6. 按自动化类型分類的实验室自动化市场

  • 介绍
  • 模组化的
  • 全自动型

第七章：按应用分類的实验室自动化市场

  • 介绍
  • 免疫诊断
  • 分子诊断
  • 药物研发
  • 血液分析
  • 其他的

第八章：按最终用户分類的实验室自动化市场

  • 介绍
  • 医院和诊断中心
  • 製药和生物技术公司
  • 研究和学术机构

9. 按地区分類的实验室自动化市场

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十一章：公司简介

  • Danaher Corporation
  • Abbott Laboratories
  • PerkinElmer, Inc.
  • Tecan Trading AG
  • Synchron
  • Hudson Robotics Inc.
  • F. Hoffmann-La Roche AG
  • Scienion AG
  • Thermo Fisher Scientific
  • COPAN ITALIA spa
  • Horiba, Ltd.
  • Oracle Corporation
  • HighRes Biosolutions

第十二章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061612280

The Laboratory Automation Market will rise from USD 5.406 billion in 2025 to USD 7.671 billion in 2030, with a 7.25% compound annual growth rate (CAGR).

Laboratory automation systems employ advanced instrumentation to streamline laboratory processes with minimal human intervention, enhancing efficiency, accuracy, and safety. These systems optimize tasks from single steps to entire workflows, reducing reagent use, minimizing waste, and increasing experimental throughput. The global laboratory automation market is poised for steady growth, driven by growing awareness of automation benefits, technological advancements, and rising investments in drug discovery and biotechnology. However, high production and deployment costs, along with slower adoption among small and medium-sized enterprises (SMEs), may impede market expansion.

Market Drivers

Hardware Segment Dominance

The hardware segment, encompassing laboratory robotics and automated workstations, holds the largest market share. The increasing need for accelerated research and pharmaceutical development fuels demand for these components, as they enhance productivity and streamline complex processes. Automated workstations, in particular, are adopted for their ability to handle high workloads efficiently, supporting scalability in laboratory operations and driving market growth.

Clinical Chemistry Applications

The clinical chemistry segment dominates due to its reliance on automation to manage high workloads with reduced manpower. The growing need for specialized laboratories with automated functions, such as result management, storage, and archiving, further boosts demand. Automation in clinical chemistry enhances precision and reduces lead times, aligning with the industry's push for operational efficiency and data reliability.

Market Restraints

High costs associated with developing and deploying automation systems pose a significant barrier, particularly for SMEs with limited budgets. Additionally, the slower adoption of advanced technologies in smaller labs, due to insufficient infrastructure or expertise, limits market penetration. These challenges necessitate cost-effective solutions and increased awareness to broaden adoption.

Market Segment Analysis

By offering, the market is divided into hardware and software, with hardware leading due to its critical role in automation systems. By application, clinical chemistry holds a dominant share, driven by high-throughput needs, followed by drug discovery and genomics. The biotechnology and pharmaceutical companies segment is the largest end-user, propelled by the need to manage product complexity, reduce operational costs, and accelerate drug development through automation. Other end-users include academic research and clinical diagnostics.

Geographically, North America commands the largest market share, supported by advanced healthcare infrastructure, widespread adoption of innovative technologies, and the presence of major players. The Asia-Pacific region is expected to experience the fastest growth, driven by increasing healthcare investments, rapid R&D sector development, and growing technology adoption in countries like China and India.

Competitive Landscape

Key players, such as F. Hoffmann-La Roche AG, are driving innovation through advanced solutions like AI, machine learning, and robotics. These companies pursue collaborative strategies, including product launches and partnerships, to expand their market presence across diverse applications. The focus is on delivering scalable, efficient automation systems that enhance productivity and data accuracy for end-users in biotechnology and pharmaceuticals.

Regional Analysis

North America's dominance stems from its robust healthcare ecosystem and early adoption of automation technologies. The Asia-Pacific region, however, is a hotspot for growth, fueled by rising healthcare infrastructure investments and expanding R&D activities. Emerging markets in South America also present opportunities, though adoption lags due to cost constraints.

The laboratory automation market is set for robust growth, driven by hardware advancements, clinical chemistry applications, and biotechnology/pharmaceutical demands. North America leads, while Asia-Pacific's rapid development signals strong potential. High costs and SME adoption barriers pose challenges, but ongoing innovations in AI and robotics, coupled with strategic investments, will sustain market momentum, enhancing efficiency and safety in laboratory processes.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The Laboratory Automation Market is analyzed into the following segments:

By Component

  • Hardware
  • Software
  • Services

By Automation Type

  • Modular
  • Fully-Automated

By Application

  • Immunodiagnostics
  • Molecular Diagnostics
  • Drug Development
  • Hematology
  • Others

By End-User

  • Hospitals & Diagnostics Centers
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LABORATORY AUTOMATION MARKET BY COMPONENT

  • 5.1. Introduction
  • 5.2. Hardware
  • 5.3. Software
  • 5.4. Services

6. LABORATORY AUTOMATION MARKET BY AUTOMATION TYPE

  • 6.1. Introduction
  • 6.2. Modular
  • 6.3. Fully-Automated

7. LABORATORY AUTOMATION MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Immunodiagnostics
  • 7.3. Molecular Diagnostics
  • 7.4. Drug Development
  • 7.5. Hematology
  • 7.6. Others

8. LABORATORY AUTOMATION MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Diagnostics Centers
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Academic Institutes

9. LABORATORY AUTOMATION MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Danaher Corporation
  • 11.2. Abbott Laboratories
  • 11.3. PerkinElmer, Inc.
  • 11.4. Tecan Trading AG
  • 11.5. Synchron
  • 11.6. Hudson Robotics Inc.
  • 11.7. F. Hoffmann- La Roche AG
  • 11.8. Scienion AG
  • 11.9. Thermo Fisher Scientific
  • 11.10. COPAN ITALIA spa
  • 11.11. Horiba, Ltd.
  • 11.12. Oracle Corporation
  • 11.13. HighRes Biosolutions

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations